Navigation Links
PIT(-1)ting good and bad outcomes against each other in breast cancer
Date:11/8/2010

The outlook for patients with breast cancer is determined in part by whether or not their tumor has spread to other sites in the body. A team of researchers, led by Roman Perez-Fernandez and colleagues, at the University of Santiago de Compostela, Spain, has now identified in a subset of patients with breast cancer, a marker associated with the occurrence of tumors at distant sites; a finding that they hope might help predict a patient's outlook more accurately. Specifically, the team found that in patients with breast cancer that was accompanied by the presence of tumor cells in nearby lymph nodes, high levels of expression of the protein Pit-1 were associated with tumor spread to distant sites. The authors therefore suggest that analysis of Pit-1 expression in human breast tumor samples could help predict the outlook for patients with lymph nodepositive breast cancer.


'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related medicine news :

1. Molecular pathways linked to sex, age affect outcomes in lung cancer
2. Medicare data reveals differences in orthopedic surgical outcomes
3. H1N1 learnings: Risk factors for severe outcomes among patients admitted to hospital with H1N1
4. Small to Mid-Sized Hospitals Turn to Orion Health to Implement Health IT Solutions for Improved Patient Care and Outcomes
5. Few differences in outcomes between open and laparoscopic prostate surgery
6. Evidence-based care and outcomes improve at Get With The Guidelines-Stroke hospitals
7. Short on specialized intensive care physicians, team-based approach improves ICU outcomes
8. Researchers receive NIH grant to study predictors and outcomes of autoimmune lung disease
9. Aggressive response helped Chilean hospital improve H1N1 influenza outcomes
10. Pretreatment SUV associated with head and neck cancer treatment outcomes, may help decide treatment plans
11. National Alliance for Hispanic Health Urges Action on Insurance Access as First Step to Achieving Best Health Outcomes for All
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... ... The Lung Institute has partnered with the Gulfcoast North Area ... at their clinic in downtown Tampa. The class is complimentary for the public. Register ... a free downloadable 4 Week Smoking Cessation Guide for those who are ...
(Date:5/26/2016)... ... 26, 2016 , ... American orthopedic surgeon and internationally recognized ... Horizon International (BHI), Brian Mehling, M.D., spoke at an International Conference and Expo ... in Chicago, IL, USA. Dr. Mehling’s presentation was focused on stem cell therapy ...
(Date:5/26/2016)... TN (PRWEB) , ... May 26, 2016 , ... ... fitness education and products recently hosted the first PowerWave Instructor Certification Course in ... who lead a group of fitness professional through the 8 hour interactive course ...
(Date:5/26/2016)... ... 2016 , ... On May 23rd during the National Eye Institute’s “Healthy Vision ... advocate, was honored by Ashram, Inc. as the world’s foremost water visionary. , “Sharon ... banks of the Nile to fill their red clay pots with life-sustaining water.” Said ...
(Date:5/26/2016)... ... May 26, 2016 , ... Workrite Ergonomics ... leadership and to further develop their rapidly expanding portfolio of customer and end ... a concentration in Marketing and an M.B.A. with concentration in management from Bryant ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... Frankfurt Prime Standard: QIA) today announced that the company has ... GmbH to develop and commercialize predictive assays in oncology. An ... a marker to predict effectiveness of anthracycline treatment in triple ... are pleased to partner with Therawis, which developed the PITX2 ...
Breaking Medicine Technology: